![](/img/cover-not-exists.png)
Deficient activation of Bak and Bax confers resistance to gemtuzumab ozogamicin-induced apoptotic cell death in AML
Petra Haag, Kristina Viktorsson, Marita Lagergren Lindberg, Lena Kanter, Rolf Lewensohn, Leif StenkeVolume:
37
Year:
2009
Language:
english
Pages:
12
DOI:
10.1016/j.exphem.2009.03.002
File:
PDF, 1.01 MB
english, 2009